Quantitative Measurement of Serum MicroRNA-21 Expression in Relation to Breast Cancer Metastasis in Chinese Females

Guinian Wang; Longzi Wang; Sijing Sun; Juan Wu; Qinglu Wang

Quantitative Measurement of Serum MicroRNA-21 Expression in Relation to Breast Cancer Metastasis in Chinese Females

Recommendations

Search

Type: Academic journal

Author: Guinian Wang Longzi Wang Sijing Sun Juan Wu Qinglu Wang

Journal: 대한진단검사의학회 Annals of Laboratory Medicine Annals of Laboratory Medicine 제35권 제2호 KCI Accredited Journals

Published: 2015.1

Pages: 226 - 232 (7page)

Usage

Quantitative Measurement of Serum MicroRNA-21 Expression in Relation to Breast Cancer Metastasis in Chinese Females

Abstract· Keywords

Report Errors

Background: Breast cancer is the most common type of cancer in females. Aberrant expression of microRNA-21 (miR-21) has previously been reported in breast cancer tissue. The aim of this study was to investigate expression levels of serum miR-21 in breast cancer patients and evaluate its prognostic value in Chinese females. Methods: Real-time quantitative (RQ)-PCR was used to analyze miR-21 expression in archived serum, tumor tissue, and adjacent normal tissue from 549 participants (326 with breast cancer, 223 without breast cancer). We also analyzed associations between serum miR-21 expression and breast cancer subtypes and patient prognosis. Recurrence and survival were analyzed by using the multivariate Cox proportional hazards model. Results: Expression of miR-21 was significantly higher in breast cancer tissues compared with normal adjacent breast tissues (P<0.001). The 2-ΔΔCt values for serum miR-21 in breast cancer patients versus healthy controls were 9.12±3.43 and 2.96±0.73, respectively. Multivariate Cox proportional hazards model suggested that serum miR-21 expression was an independent poor prognostic factor for both recurrence (hazard ratio [HR]= 2.942; 95% confidence interval [CI]=1.420-8.325; P=0.008) and disease-free survival (HR=2.732; 95% CI=1.038-7.273, P=0.003) in breast cancer. Conclusions: Increased serum miR-21 expression level was correlated with poor prognosis of breast cancer patients, indicating that serum miR-21 may be a novel prognostic marker for recurrence and survival of breast cancer patients before resection.

#Biomarker #Breast cancer #Prognosis #Serum miR-21

No content found

References (26)

Add References

Asaga S / 2011 / Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer / Clin Chem 57 : 84 ~ 91

Calin GA / 2004 / Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers / Proc Natl Acad Sci USA 101 : 2999 ~ 3004

Calin GA / 2007 / Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications / J Clin Invest 117 : 2059 ~ 2066

Chan M / 2013 / Identification of circulating microRNA signatures for breast cancer detection / Clin Cancer Res 19 : 4477 ~ 4487

Cortez MA / 2011 / MicroRNAs in body fluids--the mix of hormones and biomarkers / Nat Rev Clin Oncol 8 : 467 ~ 477

Recommendations

It is an article recommended by DBpia according to the article similarity. Check out the related articles!